Introduction
In the adult mouse the bone marrow serves as the major site for blood cell production and development. The large majority of the cells present in the bone marrow are relatively mature and derived from a small proportion designated as hematopoietic stem cells. These cells are capable of developing into all mature blood cell types and have the capacity of serf renewal. Hematopoietic stem cells represent approximately 0.05% of cells in the bone marrow, but they are thought to be responsible for short-term and long-term repopulation of hematopoietic tissues in the host following lethal irradiation and transplantation. Over the past years, methods have been developed to purify and identify hematopoietic stem cells, allowing functional characterization in in vitro and in vivo assays.
Purification of progenitor cells
The purification of hematopoietic progenitor cells has relied on methods that exploit differences in densities and in cell surface antigen expression. In the mouse it has been possible to obtain almost pure populations of bone marrow derived stem cells using lineage depletion and positive selection with monoclonal antibodies [1] . Another procedure used to purify stem cells involves the use of the fluorescent dye Rhodamine 123 (Rho). Ploemacher [2, 3] . Recently, it has been shown that Rho is a substrate for transport mediated by P-glycoprotein, an energydependent efflux probe responsible for multidrug resistance in tumour cells [4, 5] . P-glycoprotein is the product of the MDR-1 gene and its transport can be blocked by substances like cyclosporin-A or verapamil. Its expression on human hematopoietic progenitor cells [6] may indicate that P-glycoprotein may protect these cells against the toxic effect of chemotherapeutic agents like vinca alkaloids, anthracyclines and taxoids.
Indeed, mice overexpressing the human MDR gene were found to be relatively resistant to the myelosuppressive effect of anthracyclines [7] .
In our studies we have employed a modified Rho staining procedure comprising two sequential Rho staining steps and blocking of P-glycoprotein using verapamil, to purify murine hematopoietic stem cells.
Bone marrow reconstitution following lethal irradiation and transplantation
Hematopoietic reconstitution following transplantation requires the presence of hematopoietic stem cells that provide long-term repopulating ability in lymphoid and myeloid lineages. Since the development from stem cell to mature end-cell requires multiple cell divisions, cells exhibiting long-term repopulating ability require a period of several weeks to proliferate and differentiate into mature end-cells. Therefore, it is commonly accepted that a second population of cells exhibiting short-term repopulating ability or radioprotection is required to protect the host against the lethal complications of radiation. Committed progenitor cells are thought to mediate short-term repopulating ability ( Figure 1 ). In spite of this widely accepted concept, there are relatively few data that demonstrate the requirement of committed progenitor cells for short-term engraftment. Jones et al. have used elutriated bone marrow cells to separate relatively mature cells from relatively immature hematopoietic stem cells [8] . Cells derived from the lymphocyte-like cell fraction were unable to provide survival of lethally irradiated recipient mice, but exhibited long-term repopulation if cotransplanted with helper cells from the large-cell fraction. These results suggested the existence of a population of stem cells exhibiting only long-term repopulating ability. These findings contrast with other reports employing highly purified stem cell populations that appeared to exhibit good radioprotective capacity [1, [9] [10] [11] [12] [13] . The apparent discrepancy between these studies may be explained by the frequency of stem cells in the elutriated cell population reported by Jones. It can be calculated that the cell fraction exhibiting LTRA contained less than 10 hematopoietic stem cells. In accordance with other studies, this number is insufficient to provide radioprotective capacity in the majority of the recipients. Thus, provided that sufficient numbers of stem cells are transplanted in the range of several hundreds per mouse, hematopoietic stem cell populations that mediate long-term repopulation, but lack radioprotective capacity, have not yet been reported. We therefore decided to undertake a series of experiments to address the issue of short-term and longterm repopulating stem cells following syngeneic transplantation in a murine model.
Identification and characterization of murine bone marrow-derived stem cells with preferential short-term and long-term bone marrow repopulating ability
In order to separate cells with short-term repopulating ability (STRA) from those with long-term repopulating ability (LTRA), transplant experiments in mice were performed with subsets of relatively mature and relatively immature hematopoietic progenitor cells [14] . In these studies, mouse (Balb-C) bone marrow cells were enriched for progenitor cells using Wheat-Germ Agglutinin (WGA) and the monoclonal antibody 15.1.1. that recognizes relatively mature myeloid cells. The WGA + 15.1.1. -enriched cell suspensions were further purified using Rhodamine 123 (Rho) fluorescence. As a first step, cells were incubated with Rho at a concentration of 0.1 mg/ml for 20 minutes at 37 °C. Cells were washed twice at room temperature, resuspended and incubated in medium without Rho for 20 minutes at 37 "C. This resulted in populations of Rho bright (Rho* 4 ), dull (Rho + ) and Rho negative cells (Rho~) (Figure 2 ). To improve the distinction between Rho" and Rho + cells, the procedure was modified in that an excitation and emission wave length of 514 and 518 nm was used rather than the standard excitation and emission wave length of 488 and 530 nm. The female recipient animals. These experiments indicated that radioprotection was mainly derived from the Rho~/Rh(VP) + cells, whereas long-term repopulating ability in recipients at 6 months after transplantation was mainly present in the Rho~/Rh(VP)~ cells, but also to a considerable extent in the RhoVRh(VP) + cells. To exclude the possibility of lineage specific long-term repopulation, chimerism was performed in myeloid cells in the bone marrow, T-cells in the thymus and B lymphocytes in the spleen. Since a majority of the cells in these organs was donor-derived, these results indicated the transplantation of true stem cells exhibiting longterm lymphomyeloid repopulating ability. Moreover, these experiments indicate the existence of a subpopulation of cells (Rho~ cells) that contains both short-term (STRA) and long-term (LTRA) repopulating stem cells.
Engraftment following transplantation of cytokinemobilized blood
Transplantation of cytokine-mobilized blood cells is rapidly replacing autologous bone marrow transplantation because of the significant acceleration of hematopoietic reconstitution. This advantage is thought to be mediated by committed progenitor cells that are responsible for the early phase of engraftment. This concept is supported by several lines of evidence. Cytokine-mobilized blood cell grafts contain a significantly higher number of committed progenitor cells than bone marrow grafts. In addition, the maturation of relatively mature committed progenitor cells requires relatively little time, while the development of immature progenitor cells and stem cells may require a longer period of time. Based on this concept, ex vivo expansion is undertaken in an attempt to further increase the number of committed progenitor cells and post-progenitor cells in a stem cell graft with the ultimate purpose to further accelerate hematopoietic reconstitution after transplantation.
In an attempt to further delineate the role of committed progenitor cells and stem cells in the early and late phase of engraftment, we performed experiments using purified stem cell subsets in a murine syngeneic transplant model [15] .
Balb-C donor mice were treated with cyclophosphamide (400 mg/kg/ip day 0) and human recombinant G-CSF (5 mg/day/sc days 1-5). Peripheral blood derived sorted WGA + , 15.1.1." (WGA + Lin") cells were then stained in an identical way with Rho (20 min, 37 6 C, 0.1 mg/ml) followed by washing and incubation in Rho-free medium (20 min, 37 °C). This resulted in distinct populations of Rho" 1^, Rho + and Rho" cells. The Rho" cell fraction, comprising 5%-8% of WGA + Lin~ bone marrow cells was decreased to 0.2%-1.2% in cytokine-mobilized blood. Cultures were performed supplemented with GM-CSF (10 ng/ml), G-CSF (10 ng/ml), mu IL-3 (25 ng/ml), and hu-erythropoietin (2 U/ml). The majority, i.e., more than 95% of all colonyforming cells in both bone marrow and peripheral blood were present in the Rho + / ++ cell fraction. In addition, the proportion of Rho + / ++ cells was increased in cytokine mobilized-blood in comparison with bone marrow. In radioprotection experiments, cytokine-mobilized blood cells derived from male donors were transplanted into lethally irradiated (8.5 Gy) female recipient animals. The 50% radioprotection rate was obtained after transplantation of 50 Rho", 3,000 Rho + and 20,000 Rho 4 " 1 " peripheral blood derived cells. These results indicate that the WAGV15.1.1"/Rho" cell fraction that mediates radioprotection and LTRA following transplantation of bone marrow [14] , also mediates radioprotection after transplantation of cytokine-mobilized blood. In contrast, the Rho + / ++ cell fraction, containing >95% of colony-forming cells, has no radioprotecn've capacity.
Discussion
Our results indicate that hematopoietic reconstitution following transplantation is mediated by a population of hematopoietic stem cells. This not only applies for long-term repopulation, but also for short-term repopulation required for radioprotection. The results obtained with bone marrow derived stem cells and cytokine-mobilized blood derived cells are remarkably similar in that the Rho" cell fraction appeared to contain short-term and long-term repopulating hematopoietic stem cells. Thus, the cells are not only phenotypically identical but appear to have a similar functional behaviour upon transplantation into lethally irradiated recipients. Previous studies of other groups have indicated that Rho duU cells are relatively primitive in comparison with Rho bnght cells in that they have radioprotective capacity but do not form spleen colonies following transplantation [3] . In these studies, Rho du " cells comprised cells that were truly Rho" as well as cells that were Rho duU . In our studies we have employed a different Rho staining method that allowed us to distinguish Rho" cells from Rho du " cells. Our studies indicate that Rho duU cells and the Rho" cells differ in repopulating ability and show that a single population of cells is responsible for early (radioprotection) and long-term engraftment following transplantation. Our results suggest that the contribution of relatively mature cells, i.e., committed progenitor cells to the early phase of engraftment, if any, is very little.
Clearly, these results have implications for ex vivo expansion, where large increases in the numbers of committed progenitor cells are being obtained with the purpose to further accelerate reconstitution after transplantation. Several groups have reported accelerated reconstitution following transplantation of increased numbers of committed progenitor cells in mice [16, 17] . In these experiments, bone marrow cells were used obtained from 5 fluorouracil pretreated mice, as a method to in vivo deplete cycling progenitor cells. Transplanta-tion of these cells resulted in relatively delayed engraftment that could be corrected by adding ex vivo expanded cells containing large numbers of committed progenitor cells [16] . These studies therefore suggest that transplantation of in vivo selected immature hematopoietic progenitor cells may be associated with delayed engraftment that can be corrected by adding ex vivo expanded cells. Since the expanded cells comprise the heterogeneous population of relatively mature and immature cells, the studies do not provide convincing evidence for the role of committed progenitor cells.
Other studies indicate a decrease in marrow repopulating ability following ex vivo or in vivo expansion of hematopoietic stem cells. Spangrude et al. have isolated purified stem cells from primary recipients that were transplanted with hematopoietic stem cells isolated from normal mouse bone marrow based on surface antigen expression and low retention of Rho [13] . They observed an increase in the numbers of cells expressing the cell surface phenotype of stem cells (Thy-l.l lowLin ne sLy-6A/E + Rho low ). These cells formed spleen colonies from transplantation into lethally irradiated recipients, but their long-term reconstitution potential in comparison with freshly isolated stem cells was clearly decreased. These results indicate that stem cells that maintained their primitive phenotype exhibited decreased repopulating potential. Rebel [18] et al. have purified Sca-1 + Lin~ WGA + stem cells for ex vivo cultures in serum-free medium containing steel factor (SCF), IL-6 and erythropoietin. Following a culture period of two weeks they observed an approximate 10-fold increase in the number of cells exhibiting the primitive Sca-1 + Lin" WGA + phenotype. Transplantation of irradiated recipient animals with these cultured primitive cells showed that the long-term repopulating ability of these cells was similar to the initially purified stem cells.
In conclusion, the available evidence so far does not allow a firm conclusion with respect to cell types that are responsible for rapid engraftment observed after blood stem cell transplantation. Clearly, experiments using purified populations of primitive stem cells and committed progenitor cells will be required to resolve these issues.
